Potential Role for the Use of Gliptins in Cystic Fibrosis-related Diabetes

Files
Potential Role for the Use of Gliptins in Cystic Fibrosis-related Diabetes - PM.pdf (276.89 KB)
If you need an accessible version of this item, please email your request to digschol@iu.edu so that they may create one and provide it to you.
Date
2021-10-21
Authors
Ismail, Heba M.
Language
American English
Embargo Lift Date
Department
Pediatrics, School of Medicine
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Endocrine Society
Abstract
Description
Keywords
DDP-4 inhibitor, Abnormal glucose tolerance, Cystic fibrosis-related diabetes, Glucagon, Glucagon-like peptide1 (GLP-1), Glucose-dependent insulinotropic polypeptide, Incretin, Insulin, Sitagliptin
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Ismail HM. Potential Role for the Use of Gliptins in Cystic Fibrosis-related Diabetes. J Clin Endocrinol Metab. 2021;106(11):e4786-e4788. doi:10.1210/clinem/dgab442
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
The Journal of Clinical Endocrinology & Metabolism
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International Creative Commons licenses
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/31981
DOI
https://doi.org/10.1210/clinem/dgab442
Version
Full Text Available at
This item is under embargo {{howLong}}
Collections
Open Access Policy Articles
Department of Pediatrics Works